US Patent Issued to REVANCE THERAPEUTICS on Sept. 15 for "Injectable botulinum toxin formulations and methods of use thereof having long duration of therapeutic or cosmetic effect" (California Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,226, issued on Sept. 15, was assigned to REVANCE THERAPEUTICS INC. (Newark, Calif.).

"Injectable botulinum toxin formulations and methods of use thereof having long duration of therapeutic or cosmetic effect" was invented by Curtis L. Ruegg (Redwood City, Calif.) and Jacob M. Waugh (Palo Alto, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides novel injectable compositions comprising botulinum toxin that may be administered to a subject for various therapeutic, aesthetic and/or cosmetic purposes. The injectable compositions embraced by the invention exhibit one or more advantages over conventional botulinum toxin formulat...